BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34185406)

  • 1. A consistent arrhythmogenic trait in Brugada syndrome cellular phenotype.
    Al Sayed ZR; Jouni M; Gourraud JB; Belbachir N; Barc J; Girardeau A; Forest V; Derevier A; Gaignerie A; Chariau C; Cimarosti B; Canac R; Olchesqui P; Charpentier E; Schott JJ; Redon R; Baró I; Probst V; Charpentier F; Loussouarn G; Zibara K; Lamirault G; Lemarchand P; Gaborit N
    Clin Transl Med; 2021 Jun; 11(6):e413. PubMed ID: 34185406
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.
    Liang P; Sallam K; Wu H; Li Y; Itzhaki I; Garg P; Zhang Y; Vermglinchan V; Lan F; Gu M; Gong T; Zhuge Y; He C; Ebert AD; Sanchez-Freire V; Churko J; Hu S; Sharma A; Lam CK; Scheinman MM; Bers DM; Wu JC
    J Am Coll Cardiol; 2016 Nov; 68(19):2086-2096. PubMed ID: 27810048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A second case with arrhythmogenic cardiomyopathy, provocable Brugada ECG and SCN5A mutation.
    S P
    Int J Cardiol; 2014 Feb; 171(3):e117-8. PubMed ID: 24388542
    [No Abstract]   [Full Text] [Related]  

  • 4. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Models of Brugada syndrome.
    Sendfeld F; Selga E; Scornik FS; Pérez GJ; Mills NL; Brugada R
    Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31032819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switch From Fetal to Adult
    Veerman CC; Mengarelli I; Lodder EM; Kosmidis G; Bellin M; Zhang M; Dittmann S; Guan K; Wilde AAM; Schulze-Bahr E; Greber B; Bezzina CR; Verkerk AO
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28739862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype.
    Cerrone M; Lin X; Zhang M; Agullo-Pascual E; Pfenniger A; Chkourko Gusky H; Novelli V; Kim C; Tirasawadichai T; Judge DP; Rothenberg E; Chen HS; Napolitano C; Priori SG; Delmar M
    Circulation; 2014 Mar; 129(10):1092-103. PubMed ID: 24352520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium channel current loss of function in induced pluripotent stem cell-derived cardiomyocytes from a Brugada syndrome patient.
    Selga E; Sendfeld F; Martinez-Moreno R; Medine CN; Tura-Ceide O; Wilmut SI; Pérez GJ; Scornik FS; Brugada R; Mills NL
    J Mol Cell Cardiol; 2018 Jan; 114():10-19. PubMed ID: 29024690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hiPSC-derived cardiomyocytes from Brugada Syndrome patients without identified mutations do not exhibit clear cellular electrophysiological abnormalities.
    Veerman CC; Mengarelli I; Guan K; Stauske M; Barc J; Tan HL; Wilde AA; Verkerk AO; Bezzina CR
    Sci Rep; 2016 Aug; 6():30967. PubMed ID: 27485484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elementary mechanisms of calmodulin regulation of Na
    Kang PW; Chakouri N; Diaz J; Tomaselli GF; Yue DT; Ben-Johny M
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34021086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brugada syndrome disease phenotype explained in apparently benign sodium channel mutations.
    Hoshi M; Du XX; Shinlapawittayatorn K; Liu H; Chai S; Wan X; Ficker E; Deschênes I
    Circ Cardiovasc Genet; 2014 Apr; 7(2):123-31. PubMed ID: 24573164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene-edited human-induced pluripotent stem cell-derived cardiomyocytes and preclinical drug screening.
    El-Battrawy I; Lan H; Cyganek L; Maywald L; Zhong R; Zhang F; Xu Q; Lee J; Duperrex E; Hierlemann A; Saguner AM; Duru F; Kovacs B; Huang M; Liao Z; Albers S; Müller J; Dinkel H; Rose L; Hohn A; Yang Z; Qiao L; Li Y; Lang S; Kleinsorge M; Mügge A; Aweimer A; Fan X; Diecke S; Akin I; Li G; Zhou X
    Clin Transl Med; 2021 Dec; 11(12):e646. PubMed ID: 34954893
    [No Abstract]   [Full Text] [Related]  

  • 13. Readthrough-Promoting Drugs Gentamicin and PTC124 Fail to Rescue Nav1.5 Function of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Carrying Nonsense Mutations in the Sodium Channel Gene SCN5A.
    Kosmidis G; Veerman CC; Casini S; Verkerk AO; van de Pas S; Bellin M; Wilde AA; Mummery CL; Bezzina CR
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27784737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiac sodium channelopathy from bench to bedside].
    Zhang YM; Zhou N
    Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):874-7. PubMed ID: 24484568
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparing human iPSC-cardiomyocytes versus HEK293T cells unveils disease-causing effects of Brugada mutation A735V of Na
    de la Roche J; Angsutararux P; Kempf H; Janan M; Bolesani E; Thiemann S; Wojciechowski D; Coffee M; Franke A; Schwanke K; Leffler A; Luanpitpong S; Issaragrisil S; Fischer M; Zweigerdt R
    Sci Rep; 2019 Aug; 9(1):11173. PubMed ID: 31371804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes.
    El-Battrawy I; Albers S; Cyganek L; Zhao Z; Lan H; Li X; Xu Q; Kleinsorge M; Huang M; Liao Z; Zhong R; Rudic B; Müller J; Dinkel H; Lang S; Diecke S; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou X; Akin I
    Europace; 2019 Sep; 21(9):1410-1421. PubMed ID: 31106349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brugada syndrome trafficking-defective Nav1.5 channels can trap cardiac Kir2.1/2.2 channels.
    Pérez-Hernández M; Matamoros M; Alfayate S; Nieto-Marín P; Utrilla RG; Tinaquero D; de Andrés R; Crespo T; Ponce-Balbuena D; Willis BC; Jiménez-Vazquez EN; Guerrero-Serna G; da Rocha AM; Campbell K; Herron TJ; Díez-Guerra FJ; Tamargo J; Jalife J; Caballero R; Delpón E
    JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human model of IRX5 mutations reveals key role for this transcription factor in ventricular conduction.
    Al Sayed ZR; Canac R; Cimarosti B; Bonnard C; Gourraud JB; Hamamy H; Kayserili H; Girardeau A; Jouni M; Jacob N; Gaignerie A; Chariau C; David L; Forest V; Marionneau C; Charpentier F; Loussouarn G; Lamirault G; Reversade B; Zibara K; Lemarchand P; Gaborit N
    Cardiovasc Res; 2021 Jul; 117(9):2092-2107. PubMed ID: 32898233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor homologous factors tune arrhythmogenic late NaV1.5 current in calmodulin binding-deficient channels.
    Abrams J; Roybal D; Chakouri N; Katchman AN; Weinberg R; Yang L; Chen BX; Zakharov SI; Hennessey JA; Avula UMR; Diaz J; Wang C; Wan EY; Pitt GS; Ben-Johny M; Marx SO
    JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32870823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Sodium Channel Mutations: Why so Many Phenotypes?
    Liu M; Yang KC; Dudley SC
    Curr Top Membr; 2016; 78():513-59. PubMed ID: 27586294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.